AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2018
Jan 12, 2018
34705_dirs_2018-01-12_479d83fe-9687-4514-97b9-79453bf60aea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2018-01-10
Reporting Person: MUKUNDA RAM (Director, Exec. Chairman & CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-10 | Common stock | S | 7738 | $1.11 | Disposed | 2384256 | Direct |
| 2018-01-10 | Common stock | S | 1203 | $1.08 | Disposed | 2383053 | Direct |
| 2018-01-10 | Common stock | S | 3059 | $1.07 | Disposed | 2379994 | Direct |
| 2018-01-11 | Common stock | S | 8000 | $1.12 | Disposed | 2371994 | Direct |
| 2018-01-11 | Common stock | S | 4000 | $1.11 | Disposed | 2367994 | Direct |
| 2018-01-12 | Common stock | S | 12000 | $1.05 | Disposed | 2355994 | Direct |
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15